Literature DB >> 1382431

Identification of antigenic regions of the human Ro 60 kDa protein using recombinant antigen and synthetic peptides.

M Wahren1, U Rudén, B Andersson, N R Ringertz, I Pettersson.   

Abstract

Autoantibodies reacting with the human Ro 60 kDa protein are present in anti-Ro/SS-A positive sera from patients with several different connective tissue diseases including Sjögren's syndrome and systemic lupus erythematosus. To investigate the humoral immune response to this protein, the pattern of antibody recognition of recombinant Ro 60 kDa proteins encoded by both full-length and deletion clones was analysed by immunoblotting. An antigenic region recognized by nearly all anti-Ro 60 kDa positive sera was found to reside in the middle part of the protein. In addition, some sera reacted with two other antigenic regions located in the amino-terminal and carboxyl-terminal part of the protein. For further mapping, overlapping peptides covering the most frequently recognized region of the protein were synthesized by solid-phase methods and used as antigens in ELISA. Three major patterns of reactivity to Ro 60 kDa peptides were found. These results not only indicate the presence of an immunodominant region but also heterogeneity in the autoimmune human response to the Ro 60 kDa antigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382431     DOI: 10.1016/0896-8411(92)90146-h

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  N Pourmand; M Wahren-Herlenius; I Gunnarsson; E Svenungsson; B Löfström; Y Ioannou; D A Isenberg; C G Magnusson
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.

Authors:  A G Terzoglou; J G Routsias; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; M Wahren-Herlenius; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 4.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

5.  Human anti-Ro autoantibodies bind multiple conformational epitopes of 60-kD Ro autoantigen.

Authors:  S C Huang; R H Scofield; B T Kurien; J B Harley
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

Review 6.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

7.  Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.

Authors:  B Bozic; G J Pruijn; B Rozman; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

8.  MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production.

Authors:  M Wahren; K Skarstein; I Blange; I Pettersson; R Jonsson
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

9.  Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.

Authors:  V Ricchiuti; J P Briand; O Meyer; D A Isenberg; G Pruijn; S Muller
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

10.  Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens.

Authors:  C H Veldhoven; G J Pruijn; J F Meilof; J P Thijssen; A W Van der Kemp; W J Van Venrooij; R J Smeenk
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.